How do you decipher and target clonal evolution in myeloid malignancies?

On World AML Day we had the pleasure to be joined by Dr. Ross Levine fo Memorial Sloan Kettering Cancer Center to discuss the use of single cell technology and how it has impacted in research in AML. Dr. Ross Levine discusses the importance of clonal evolution in the fight against myeloid malignancies, and how this is uncovered directly using single cell sequencing. He said that you need to go beyond bulk sequencing to understand clonal evolution and that through clonal analysis it is possible to intercept AML before it occurs.

Learn more about Mission Bio: https://missionbio.com/ LinkedIn: https://www.linkedin.com/company/miss... Twitter: https://twitter.com/missionbio Facebook: https://www.facebook.com/missionbio Subscribe to our emails and updates: https://go.missionbio.com/l/552252/20...

Your comment